CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Shareholder vote results
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- D Other Notice of Sales of Unregistered Securities
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Other events
- SC 13D/A Stake Beneficial Ownership Report
- 8-K Event Material agreement · Unregistered share sale · Other events
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
- DEFA14A Proxy Proxy Materials
Page 16 of 50 · 996 filings